Tocilizumab in Patients With Adult-Onset Still’s Disease Refractory to Glucocorticoid Treatment: A Randomised, Double-Blind, Placebo-Controlled Phase III Trial
Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2018-213920
Full Text
Open PDFAbstract
Available in full text
Date
October 2, 2018
Authors
Publisher
BMJ